Evidence map›Paper›PMID 32612208›Full record

ReviewNature reviews. Immunology2020

Functional categories of immune inhibitory receptors.

Matevž Rumpret, Julia Drylewicz, Laura J E Ackermans, José A M Borghans, Ruslan Medzhitov, Linde Meyaard

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 92 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Immune Checkpoint Agonists for Inflammatory Skin Diseases.The Journal of investigative dermatology · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Matevž RumpretCenter for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.ORCID http://orcid.org/0000-0002-8631-8049
Julia DrylewiczCenter for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Laura J E AckermansCenter for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
José A M BorghansCenter for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.ORCID http://orcid.org/0000-0002-2931-0390
Ruslan MedzhitovDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-7021-2012
Linde MeyaardCenter for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands. l.meyaard@umcutrecht.nl.ORCID http://orcid.org/0000-0003-0707-4793
Utrecht University · NLHoward Hughes Medical Institute · USUniversity Medical Center Utrecht · NL

Funding

Role of GDF15 in the Regulation of Host Tolerance to InflammationR01AI144152 · NIAID · YALE UNIVERSITY · PI MEDZHITOV, RUSLAN · 2019 to 2023
$2.1M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI144152
6 · The paper itself

Abstract

The human genome encodes more than 300 potential immune inhibitory receptors. The reason for this large number of receptors remains unclear. We suggest that inhibitory receptors operate as two distinct functional categories: receptors that control the signalling threshold for immune cell activation and receptors involved in the negative feedback of immune cell activation. These two categories have characteristic receptor expression patterns: 'threshold' receptors are expressed at steady state and their expression remains high or is downregulated upon activation, whereas 'negative feedback' receptors are induced upon immune cell activation. We use mathematical models to illustrate their possible modes of operation in different scenarios for different purposes. We discuss how this categorization may impact the choice of therapeutic targets for immunotherapy of malignant, infectious and autoimmune diseases.

Indexed as

AnimalsAutoimmune DiseasesDown-RegulationGenome, HumanHumansReceptors, ImmunologicSignal TransductionReceptors, Immunologic

Identifiers

PMID32612208
OpenAlexW3039232686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.